NovelMed Therapeutics
OH - Cleveland
BiotechnologyFocus: Monoclonal Antibodies
NovelMed Therapeutics is a life sciences company focused on Monoclonal Antibodies.
NephrologyImmunologyRare Diseases
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
NM8074
HealthyClinical Trials (1)
NCT05642546First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult Volunteers
Phase 1NM8074
C3 GlomerulopathyClinical Trials (1)
NCT05647811Study of NM8074 in Adult C3 Glomerulopathy Patients
Phase 1/2Phase 2
Clinical Trials (1)
NCT05731050Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 2NM8074
IgA NephropathyClinical Trials (1)
NCT06454110Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
Phase 2Phase 2
Clinical Trials (1)
NCT05684159Study of NM8074 in Patients with AHUS with Evidence of Ongoing Thrombotic Microangiopathy
Phase 2Clinical Trials (1)
NCT06226662Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
Phase 2NM8074
DermatomyositisClinical Trials (1)
NCT06887738Study of NM8074 in Patients with Dermatomyositis (DM)
Phase 2Phase 2
Clinical Trials (1)
NCT05646563Study of NM8074 in Adult PNH Patients with Inadequate Response to Soliris
Phase 2Phase 2
Clinical Trials (1)
NCT05646524Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 9 clinical trials
Open Roles: 1 active job